Gables Capital Management’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
Other funds holding LEXX
Gables Capital Management's LEXX Position: Q3 2026 in Review
Gables Capital Management sold out of Lexaria Bioscience (LEXX) in Q3 2026, closing a stake of 1 share — an estimated $7 sold.
Gables Capital Management first reported a position in LEXX in Q3 2021 and held it in 19 quarters. The position peaked at $47 in Q1 2024. 15 funds tracked by Wall St. Rank hold LEXX as of Q3 2026.
- Gables Capital Management reported no remaining Lexaria Bioscience position as of Q3 2026 after selling out during the quarter.
- Gables Capital Management sold 1 Lexaria Bioscience share in Q3 2026, an estimated $7.
- Gables Capital Management first reported a position in Lexaria Bioscience in Q3 2021 and held it in 19 quarters.
- Gables Capital Management's Lexaria Bioscience position peaked at $47 in Q1 2024.
- 15 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2026.
Based on Gables Capital Management's 13F filing for Q3 2026, filed 4 Nov 2026.